Authors
Barrot H Lambdin, Jamie Humphrey, McKinley Saunders, Lynn Wenger, Ricky Bluthenthal, Paul LaKosky, Laura Guzman, Hansel Tookes, Don Des Jarlais, Sara Glick, Alex H Kral, Sheila V Patel
Published in
Drug and alcohol dependence. Volume 289. Pages 113431. Nov 13, 2026. Epub Nov 13, 2026.
Abstract
To assess whether U.S. syringe services programs (SSPs) in counties with higher levels of need in 2022 had greater financial resources and larger-scale delivery of overdose prevention interventions in 2023.
This study utilized a cross-sectional design. As a measure of underlying, community-level need, our primary exposure was 2022 county-level opioid overdose fatalities, categorized as low (1-33), moderate (34-198), or high (199-1923). Outcomes included annual SSP budget, number of naloxone recipients from the SSP, naloxone doses distributed by the SSP, and buprenorphine availability at the SSP. Using weighted generalized estimating equations with exchangeable correlation structures to account for clustering of SSPs within Census divisions, we used gamma, negative binomial, and logit specifications as appropriate for each outcome.
SSPs reported a median budget of $141,842; 596 naloxone recipients; 2001 naloxone doses distributed; and 44% had integrated buprenorphine. Compared to SSPs in low overdose fatality counties, SSPs in moderate- and high overdose fatality counties had significantly larger budgets, greater number of naloxone recipients and greater number of naloxone doses distributed. SSPs in higher need counties were not significantly more likely to have buprenorphine available (aOR=1.40; 95% CI:0.72-2.75; p = 0.321).
Our findings showed that higher levels of need were positively associated with greater financial resources for and naloxone distribution from SSPs in 2023 but was not associated with greater buprenorphine availability. Aligning higher levels of naloxone distribution with higher need maximizes potential for population health impact. Focused infrastructure and implementation support for buprenorphine integration at SSPs likely remain.
PMID:
43050840
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0